Patents by Inventor Matthew F. Myntti

Matthew F. Myntti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220184011
    Abstract: A composition that can be used to treat a wide spectrum of gram positive and gram negative bacteria, including but not limited to those in biofilm form, can be used in cilia-containing areas such as the sinus cavities and middle/inner ear, while resulting in no, or very minimal amounts of, deciliation and/or loss of function (e.g., ability to clear material from the sinus cavity). Where such a targeted treatment area includes or might include a biofilm, the composition often can detach and assist in removing the biofilm from affected tissue.
    Type: Application
    Filed: December 13, 2021
    Publication date: June 16, 2022
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20220154101
    Abstract: A composition, lethal to a broad spectrum of microorganisms and capable of repeated applications to hard surfaces, includes solvent and solute components. The solvent component includes water and a lesser amount of at least one organic liquid, while the solute component includes a weak acid, a conjugate base of that acid, an oxidizing electrolyte, and an ionic surfactant. The composition is acidic but has a pH of at least 2.5 and an effective solute concentration of at least 2.5 Osm/L.
    Type: Application
    Filed: February 1, 2022
    Publication date: May 19, 2022
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20220125045
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Application
    Filed: January 7, 2022
    Publication date: April 28, 2022
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 11273175
    Abstract: A topical composition can be used to treat or inhibit onset of fibrillar collagenous growths, including but not limited to keloids. The composition includes elemental iodine carried in a non-migratory vehicle. Application of the composition can result in a significant reduction in the size of such a growth or, if applied to an area of skin susceptible to such a growth, inhibit the onset thereof.
    Type: Grant
    Filed: June 23, 2018
    Date of Patent: March 15, 2022
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 11234435
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Grant
    Filed: November 16, 2019
    Date of Patent: February 1, 2022
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 11219208
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: January 11, 2022
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20210368788
    Abstract: A composition that can be used to treat a wide spectrum of gram positive and gram negative bacteria, including but not limited to those in biofilm form, and other microbes can be used in cilia-containing areas such as the sinus cavities and middle/inner ear, while resulting in no, or very minimal amounts of, deciliation. Where such a targeted treatment area includes a biofilm, the composition often can detach and assist in removing the biofilm from affected tissue. Many embodiments of the composition are biocompatible.
    Type: Application
    Filed: August 14, 2021
    Publication date: December 2, 2021
    Inventor: Matthew F. Myntti
  • Patent number: 11172677
    Abstract: A solid material adapted to kill bacteria in planktonic, spore and biofilm states is lethal toward a wide spectrum of gram positive and gram negative bacteria as well as other microbes. The solid material includes a significant amount of one or more surfactants entrained in a crosslinked polymeric network.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: November 16, 2021
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 11090369
    Abstract: A composition that can be used to treat a wide spectrum of gram positive and gram negative bacteria, including but not limited to those in biofilm form, and other microbes can be used in cilia-containing areas such as the sinus cavities and middle/inner ear, while resulting in no, or very minimal amounts of, deciliation. Where such a targeted treatment area includes a biofilm, the composition often can detach and assist in removing the biofilm from affected tissue. Many embodiments of the composition are biocompatible.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: August 17, 2021
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20210176987
    Abstract: A sporicidal composition has a moderately low pH and includes at least one oxidizing acid and the dissociation product of at least one inorganic oxidizing agent. Very high effective solute concentrations can enhance the efficacy of the composition. Embodiments of the composition can be applied to a surface and allowed to absorb into the endospore, ultimately killing at least some of those bacteria in mature endospore form. The surface being treated can be an inanimate surface, particularly a hard surface, or a medical device.
    Type: Application
    Filed: November 7, 2020
    Publication date: June 17, 2021
    Inventor: Matthew F. Myntti
  • Publication number: 20210037815
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Application
    Filed: October 15, 2020
    Publication date: February 11, 2021
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200390675
    Abstract: An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.
    Type: Application
    Filed: August 23, 2020
    Publication date: December 17, 2020
    Inventor: Matthew F. Myntti
  • Patent number: 10827750
    Abstract: A sporicidal composition has a moderately low pH and includes at least one oxidizing acid and the dissociation product of at least one inorganic oxidizing agent. Very high effective solute concentrations can enhance the efficacy of the composition. Embodiments of the composition can be applied to a surface and allowed to absorb into the endospore, ultimately killing at least some of those bacteria in mature endospore form. The surface being treated can be an inanimate surface, particularly a hard surface, or a medical device.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: November 10, 2020
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200315956
    Abstract: A biocompatible antimicrobial composition effective against microbial biofilms, including in vivo biofilms containing gram-positive bacteria, can be delivered to and used near the spinal column of vertebrates. Once introduced to an area colonized with a bacterial biofilm, particularly an intervertebral disc, the antimicrobial composition weakens the EPS/ECPS macromolecules of the biofilm, which makes the entire biofilm structure susceptible to being dislodged from the affected area or biosorbed. Additionally or alternatively, certain of the subcomponents of the solute component, as well as perhaps the organic liquid(s) of the solvent component, might lyse microbes, particularly gram-positive bacteria, previously protected by the EPS/ECPS macromolecules. Swelling of and around previously impacted intervertebral discs can be reduced or eliminated, often resulting in appreciable reductions in patient pain levels.
    Type: Application
    Filed: November 16, 2018
    Publication date: October 8, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Patent number: 10780037
    Abstract: An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.
    Type: Grant
    Filed: January 1, 2019
    Date of Patent: September 22, 2020
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200260723
    Abstract: A solid material adapted to kill bacteria in planktonic, spore and biofilm states is lethal toward a wide spectrum of gram positive and gram negative bacteria as well as other microbes. The solid material includes a significant amount of one or more surfactants entrained in a crosslinked polymeric network.
    Type: Application
    Filed: April 10, 2020
    Publication date: August 20, 2020
    Inventor: Matthew F. Myntti
  • Patent number: 10653133
    Abstract: A solid material adapted to kill bacteria in planktonic, spore and biofilm states is lethal toward a wide spectrum of gram positive and gram negative bacteria as well as other microbes. The solid material includes a significant amount of one or more surfactants entrained in a crosslinked polymeric network.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: May 19, 2020
    Assignee: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200113936
    Abstract: A topical composition can be used to treat or inhibit onset of fibrillar collagenous growths, including but not limited to keloids. The composition includes elemental iodine carried in a non-migratory vehicle. Application of the composition can result in a significant reduction in the size of such a growth or, if applied to an area of skin susceptible to such a growth, inhibit the onset thereof.
    Type: Application
    Filed: June 23, 2018
    Publication date: April 16, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200085038
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Application
    Filed: November 18, 2019
    Publication date: March 19, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti
  • Publication number: 20200085037
    Abstract: A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
    Type: Application
    Filed: November 16, 2019
    Publication date: March 19, 2020
    Applicant: Next Science IP Holdings Pty Ltd
    Inventor: Matthew F. Myntti